We are live on ! Find out more
STIM icon

Neuronetics

62 hedge funds and large institutions have $238M invested in Neuronetics in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 12

2.08% more ownership

Funds ownership: 69.13%71.21% (+2.1%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

16% less funds holding

Funds holding: 7462 (-12)

38% less capital invested

Capital invested by funds: $383M → $238M (-$145M)

55% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 22

Holders
62
Holders Change
-12
Holders Change %
-16.22%
% of All Funds
1.38%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
10
Increased
27
Reduced
12
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
USAA
26
United Services Automobile Association
Texas
$1.49M +$456K +20,800 +37%
GIM
27
Granahan Investment Management
Massachusetts
$1.47M +$456K +20,800 +38%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.42M +$286K +13,033 +22%
Northern Trust
29
Northern Trust
Illinois
$1.4M -$166K -7,559 -9%
FCM
30
Frontier Capital Management
Massachusetts
$1.37M +$68.6K +3,128 +5%
WRF
31
Waddell & Reed Financial
Kansas
$941K -$3.29M -150,000 -76%
Ameriprise
32
Ameriprise
Minnesota
$933K +$2.41K +110 +0.2%
JP Morgan Chase
33
JP Morgan Chase
New York
$916K +$1.01M +45,849 +3,100%
AWCI
34
Alpine Woods Capital Investors
New York
$503K +$263K +12,000 +86%
PHS
35
PFM Health Sciences
California
$444K +$503K +22,937 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$370K +$97.8K +4,458 +30%
KCM
37
Kornitzer Capital Management
Kansas
$329K
Millennium Management
38
Millennium Management
New York
$303K +$344K +15,679 New
VEA
39
Virtus ETF Advisers
New York
$296K +$335K +15,272 New
Charles Schwab
40
Charles Schwab
California
$269K
Citadel Advisors
41
Citadel Advisors
Florida
$232K +$27.2K +1,238 +11%
GCP
42
GSA Capital Partners
United Kingdom
$226K +$257K +11,700 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$193K +$7.68K +350 +4%
Morgan Stanley
44
Morgan Stanley
New York
$189K -$7.02K -320 -3%
Deutsche Bank
45
Deutsche Bank
Germany
$128K -$174K -7,920 -54%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$122K +$138K +6,300 New
CSS
47
Cubist Systematic Strategies
Connecticut
$112K +$83.1K +3,788 +189%
Bank of America
48
Bank of America
North Carolina
$111K +$115K +5,245 +968%
AIG
49
American International Group
New York
$81K -$680 -31 -0.7%
Victory Capital Management
50
Victory Capital Management
Texas
$77K

STIM Hedge Fund Activity: Q4 2018 in Review

62 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q4 2018, worth a combined $238M — down 38% from $383M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of STIM and 10 opened new positions — a net loss of 12 holders — while 12 trimmed existing stakes and 27 added.

The largest buyer was Capital Research Global Investors, adding an estimated $6.85M. The largest seller was Jennison Associates, exiting entirely with an estimated $8.22M sold.

  • 62 institutional investors held Neuronetics (STIM) as of Q4 2018, down from 74 in Q3 2018.
  • Funds reported $238M of Neuronetics stock for Q4 2018, down 38% quarter-over-quarter.
  • 10 funds opened new Neuronetics positions in Q4 2018 and 22 closed out, a net change of -12 holders.
  • The largest Neuronetics buyer in Q4 2018 was Capital Research Global Investors, an estimated $6.85M added.
  • The largest Neuronetics seller in Q4 2018 was Jennison Associates, an estimated $8.22M sold.

Based on aggregated 13F filings for Q4 2018.